Growth Metrics

Vycor Medical (VYCO) Net Income towards Common Stockholders (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Vycor Medical - - 375,153.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -126.65%
Dec 31, 2025 60.14%
Sep 30, 2025 -758.30%
Jun 30, 2025 111.90%
Mar 31, 2025 -2,879.78%
Dec 31, 2024 96.97%
Sep 30, 2024 -2,111.62%
Jun 30, 2024 94.79%
Mar 31, 2024 -107.18%
Dec 31, 2023 56.53%
Sep 30, 2023 -412.97%
Jun 30, 2023 144.04%
Mar 31, 2023 -33.27%
Dec 31, 2022 57.92%
Sep 30, 2022 -179.76%
Jun 30, 2022 58.18%
Mar 31, 2022 -26.56%
Dec 31, 2021 -18.03%
Sep 30, 2021 -1,590.76%
Jun 30, 2021 97.69%
Mar 31, 2021 -102.19%
Dec 31, 2020 44.42%
Sep 30, 2020 -44.83%
Jun 30, 2020 26.18%
Mar 31, 2020 -52.56%
Dec 31, 2019 40.56%
Sep 30, 2019 -100.64%
Jun 30, 2019 45.89%
Mar 31, 2019 28.94%
Dec 31, 2018 -53.31%
Sep 30, 2018 24.90%
Jun 30, 2018 14.37%
Mar 31, 2018 -30.31%
Dec 31, 2017 36.48%
Sep 30, 2017 -63.73%
Jun 30, 2017 24.06%
Mar 31, 2017 2.56%
Dec 31, 2016 -15.15%
Sep 30, 2016 -38.62%
Jun 30, 2016 50.42%
Sep 30, 2015 -40.89%
Jun 30, 2015 47.90%
Sep 30, 2014 -5.22%
Jun 30, 2014 -62.23%
Mar 31, 2014 -26.37%
Dec 31, 2013 -20.32%
Sep 30, 2013 19.32%
Jun 30, 2013 3.06%
Mar 31, 2013 -22.21%
Dec 31, 2012 30.94%
Sep 30, 2012 1.58%
Jun 30, 2012 -1.83%
Mar 31, 2012 8.74%
Dec 31, 2011 25.29%
Sep 30, 2011 37.39%
Jun 30, 2011 -96.14%
Mar 31, 2011 -8.17%
Dec 31, 2010 -142.31%
Sep 30, 2010 15.04%